The Reply

      I do not disagree with Dr. Nardone. I worried that including drug samples in the Web database might make it almost impossible to navigate because so many of these samples are distributed. Perhaps one might merely list the phrase “drug samples” and the cost.

      Linked Article

      • To the Editor
        The American Journal of MedicineVol. 118Issue 10
        • Preview
          I agree with the recommendation for public disclosure of transactions between physicians and pharmaceutical companies as a tool to avoid conflicts of interest.1 I do take issue with the comment to exclude the provision of medication samples from the Internet-based registry. No matter if well intended, offering samples could well be a marketing strategy to increase sales of more expensive medications, and, as such, represents a potential conflict of interest. Assume a physician offers the purple pill esomeprazole (Nexium; AstraZeneca, Wilmington, Del) as a sample for empiric treatment of gastroesophageal reflux disease.
        • Full-Text
        • PDF